Real-World Management and Survival Outcomes in Patients with Primary or Recurrent Retroperitoneal Liposarcoma: A Single-Center Retrospective Cohort Study
Abstract
Simple Summary Retroperitoneal liposarcoma is a rare cancer whose behavior differs by histological subtype. We reviewed 61 patients with primary or recurrent disease managed at a specialized cancer center, including patients who did not undergo surgery. Among 24 surgically treated patients, macroscopically complete resection was achieved in 16 of 17 primary cases and five of seven recurrent cases. Among patients with dedifferentiated liposarcoma, no difference in survival after referral between primary and recurrent disease was demonstrated. This finding does not establish an equivalent prognosis because the sample was small and patients with recurrent disease had already survived from diagnosis to referral. Associations involving poor performance status and baseline tumor size were exploratory and imprecise. These findings support a cautious multidisciplinary assessment of patient condition, disease extent, tumor burden, resectability, and prior treatment history. Larger multicenter studies are needed.